Rune Labs, a brain data company empowering the development and delivery of precision neuroscience therapeutics, today announced a $22.8 million Series A financing. The round was led by Eclipse Ventures with participation from current investors including DigiTx Partners and Moment Ventures. Justin Butler, Partner at Eclipse, will join the Rune Labs Board of Directors.

Rune Labs, Inc. is empowering the development of precision medicines for Parkinson's disease and other neurodegenerative disorders by using its software platform to make brain data useful at scale. We partner with academic collaborators to optimize clinical care for patients and with biopharma and medtech companies to enable the development of targeted treatments for patients with brain diseases. www.runelabs.io

Rune Labs Raises $22.8 Million Series A Financing To Support The Expansion Of Brain Data Software Platform

Description

Company Information

Funding Insights

Rune Labs Raises $22.8 Million Series A Financing To Support The Expansion Of Brain Data Software Platform

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Funding Insights

Company Information